STICHTING MAASTRICHT RADIATION ONCOLOGY "MAASTRO-CLINIC" Patent applications |
Patent application number | Title | Published |
20160078613 | Method and System for Determining a Phenotype of a Neoplasm in a Human or Animal Body - The present invention relates to a decision support system and an image analysis method for providing information for enabling determination of a phenotype of a neoplasm in a human or animal body for enabling prognostication, comprising the steps of: receiving, by a processing unit, image data of the neoplasm; and deriving, by the processing unit, a plurality of image feature parameter values from the image data, said image parameter values relating to image features associated with the neoplasm; and deriving, by said processing unit using a signature model, one or more neoplasm signature model values associated with the neoplasm from said image feature parameter values, wherein said signature model includes a functional relation between or characteristic values of said image feature parameter values for deriving said neoplasm signature model values | 03-17-2016 |
20150150849 | CANCER TARGETING USING CARBONIC ANHYDRASE ISOFORM IX INHIBITORS - The present invention concerns novel carbonic anhydrase IX inhibitors comprising a nitroimidazole moiety and their use in therapy of hypoxic conditions, in particular cancer treatment, especially chemotherapy and radiotherapy. The compounds of the invention have an increased specificity for the carbonic anhydrase IX enzyme compared to the art. The present invention relates to novel nitroimidazole derivates represented by formula (1), wherein R | 06-04-2015 |
20130274305 | CANCER TARGETING USING CARBONIC ANHYDRASE ISOFORM IX INHIBITORS - The present invention concerns novel carbonic anhydrase IX inhibitors comprising a nitroimidazole moiety and their use in therapy of hypoxic conditions, in particular cancer treatment, especially chemotherapy and radiotherapy. The compounds of the invention have an increased specificity for the carbonic anhydrase IX enzyme compared to the art. The present invention relates to novel nitroimidazole derivates represented by formula (1). | 10-17-2013 |